The announcement comes two months after the pair revealed at the UN General Assembly its intent to expand Zipline infrastructure to improve care access nationwide.
The company says 510(k) clearance will allow it to pursue multiple business opportunities pertaining to remote patient monitoring and clinical trials.
The patent includes the company's safety-focused LLMs incorporated into its Polaris constellation architecture.
The announcement comes about four months after Musk relayed his vision for patients with an Optimus robotic arm or leg to have the ability to control their limbs with the N1 implant.
Health AI Developer Foundations is a suite of open-weight models publicly available to help developers build and implement AI models for health applications.
Jake Leach, executive VP and chief operating officer at Dexcom, joined MobiHealthNews to discuss the company's evolution and offerings beyond diabetes.
The hybrid company offers outpatient pediatric primary and specialty care.
Elon Musk's Neuralink gets greenlit by Health Canada to perform the first trial outside of the U.S. of its brain-computer implant and robot technology.
OneCell Diagnostics scores $16 million for genomics-based precision oncology and dannce.ai, a phenotyping platform to digitize clinical assessments, secures $2.6 million.
The investment brings Oura's valuation to more than $5 billion. The partnership enables a two-way data flow between the Oura Ring and Dexcom's continuous glucose monitor.
.jpg?itok=BssI2Tm1 "Digital image of two hands touching each other through a data screen")
